 |
 |
|
|
RESÚMENES MAYO 2009 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la
información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
3! - Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Emilio Fernandez-Egea,
Miguel Bernardo, Thomas Donner, Ignacio Conget, Eduard Parellada, Azucena
Justicia, Enric Esmatjes,
Clemente Garcia-Rizo, Brian Kirkpatrick
The British
Journal of Psychiatry
(2009) 194: 434-438
3! - Cognitive
effectiveness of olanzapine and risperidone in first-episode psychosis
Manuel J. Cuesta, Elena Garcíade Jalón, M. Soledad
Campos, and Victor Peralta
The British Journal of Psychiatry 2009 v. 194, p.
439-445
3 - EEG: a helpful tool in the prediction of psychosis
Ute Gschwandtner, Marlon O. Pflueger,
Vitaliy Semenin,
Manuela Gaggiotti, Anita Riecher-Rössler and Peter Fuhr
3! - Asenapine elevates cortical dopamine, noradrenaline and serotonin release.
Evidence for activation of cortical and subcortical dopamine systems by different mechanisms
Olivia Frånberg, Monica M. Marcus,
Vladimir Ivanov, Björn Schilström,
Mohammed Shahid and Torgny H. Svensson
Psychopharmacology. Volume 204, Number 2 / June, 2009: 251-264
5 - Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone
Extended-Release and Quetiapine in Inpatients With Recently Exacerbated
Schizophrenia
Carla
M. Canuso, Bryan Dirks,
Jennifer Carothers, Colette
Kosik-Gonzalez, Cynthia A. Bossie, Young Zhu, C.V. Damaraju, Amir H. Kalali, and Ramy Mahmoud
Am J Psychiatry
Published May 1, 2009
3! - Completed suicide in schizophrenia:
Evidence from a
case-control study
Maurizio Pompili, David Lester, Alessandro
Grispini, Marco Innamorati,
Fulvia Calandro, Paolo Iliceto,
Eleonora De Pisa, Roberto Tatarelli and Paolo Girardi
Psychiatry
Research. Volume 167, Issue
3, 30 May 2009, Pages 251-257
GRATIS 3! - Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments
Paul
M. Thompson, George Bartzokis, Kiralee
M. Hayashi, Andrea D. Klunder,
Po H. Lu, Nancy Edwards, Michael S. Hong, Michael Yu, Jennifer A. Geaga, Arthur W. Toga, Cecil Charles, Diana O. Perkins,
Joseph McEvoy, Robert M. Hamer, Mauricio Tohen, Gary D. Tollefson, Jeffrey
A. Lieberman and the HGDH Study Group
Cerebral
Cortex 2009 19(5):1107-1123
3 - Sexual Problems in Patients with Schizophrenia
Daniel Schöttle, Dürten Kammerahl, Johannes Huber,
Peer Briken, Martin
Lambert, Christian G. Huber
Psychiat Prax 2009; 36: 160-168
3< - Frequency of Remission
in Schizophrenia Patients
at One Year Follow-Up
Jörg Zimmermann,
Arne Wolter, Wolfgang
Hannöver, Norbert Krischke
Psychiat Prax 2009; 36: 182-188
3 - Descriptive, open-label, long-term follow-up survey of psychotic
patients receiving risperidone long-acting injectable: Preliminary results
Annie Viala;
Françoise Cornic; Cyrine Benamor; Chantal Baldacci; Smail Cheref; Jacques Gauillard;
Pascal Martin; François
Caroli; Marie Noëlle Vacheron
3! - Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year
study
DL Kelly, E Weiner, MP
Ball, RP McMahon, WT Carpenter, RW Buchanan
Journal of Psychopharmacology, Vol. 23,
No. 4, 436-441 (2009)
3! - Association of adiponectin and metabolic syndrome
among patients taking atypical antipsychotics for schizophrenia: A cohort study
Ya Mei Bai, Tzu Ting Chen, Wei-Shiung Yang, Yu-Chao Chi, Chao-Cheng Lin,
Ying-Jay Liou, Ying-Chieh
Wang, Tung-Ping Su, Pesus Chou
and Jen-Yeu
Chen
Schizophrenia
Research. Volume 111, Issues
1-3, June 2009, Pages 1-8
4 - Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the
CAFE study
Jayendra K. Patel, Peter F. Buckley, Sandra Woolson,
Robert M. Hamer, Joseph P. McEvoy, Diana O. Perkins,
Jeffrey A. Lieberman and for
the CAFE investigators
Schizophrenia
Research. Volume 111, Issues
1-3, June 2009, Pages 9-16
4 - Effect of ziprasidone dose on all-cause
discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials
Leslie Citrome, Ruoyong Yang, Paul Glue and
Onur N. Karayal
Schizophrenia
Research. Volume 111, Issues
1-3, June 2009, Pages 39-45
3 - Genetics of weight
gain associated with antipsychotic medications
D.J. Müller, C. Peter,
I. Puls, E.J. Brandl, U.E. Lang, J. Gallinat
und A. Heinz
Der Nervenarzt.
Volume 80, Number 5 / May,
2009: 556-563
3 - Aripiprazole for the Treatment of
Schizophrenia With Co-Occurring Social Anxiety: An Open-Label Cross-Taper Study
Stern, Robert G; Petti,
Theodore A; Bopp, Kurt; Tobia,
Anthony
Journal
of Clinical Psychopharmacology: June 2009 - Volume
29 - Issue 3 - pp 206-209
2 - Synthetic [DELTA]-9-Tetrahydrocannabinol
(Dronabinol) Can Improve the Symptoms of
Schizophrenia
Schwarcz, Glenn; Karajgi, Basawaraj; McCarthy, Richard
Journal
of Clinical Psychopharmacology: June 2009 - Volume
29 - Issue 3 - pp 255-258
5 - A
Double-Blind Randomized Trial of Mood Stabilizer
Augmentation Using Lamotrigine and Valproate for Patients
With Schizophrenia Who Are Stabilized and Partially Responsive
Glick, Ira D; Bosch, Jeane;
Casey, Daniel E
Journal
of Clinical Psychopharmacology: June 2009 - Volume
29 - Issue 3 - pp 267-271
3! - Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia: An Analysis of
Correlations With Efficacy, Weight Gain, and Prolactin
Concentration
Citrome, Leslie; Stauffer, Virginia L; Chen,
Lei; Kinon, Bruce J; Kurtz, Darcie L; Jacobson, Jennie G; Bergstrom, Richard F
Journal
of Clinical Psychopharmacology: June 2009 - Volume
29 - Issue 3 - pp 278-283
2 - Glucocorticosteroids Associated With a Decreased Risk of Psychosis
Laan, Wijnand; Smeets,
Hugo; de Wit, Niek J; Kahn,
René S; Grobbee, Diederick
E; Burger, Huibert
Journal
of Clinical Psychopharmacology: June 2009 - Volume
29 - Issue 3 - pp 288-290
3 - Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
Akira Monji, Takahiro Kato,
and Shigenobu Kanba
Psychiatry and
Clinical Neurosciences. Volume 63 Issue
3, Pages 257 - 265
3 - Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia:
Kansai Psychiatric Multicenter Study
Gaku Okugawa, Masaki Kato,
Masataka
Wakeno,
Jun
Koh, Masayuki Morikawa, Naoki Matsumoto, Kazuhiro Shinosaki, Hiroshi Yoneda, Toshifumi Kishimoto, and Toshihiko
Kinoshita
Psychiatry and
Clinical Neurosciences. Volume 63 Issue
3, Pages 322 - 328
3! - Activation of the JAK-STAT pathway is necessary
for desensitization of 5-HT2A receptor-stimulated
phospholipase C signalling
by olanzapine, clozapine and MDL 100907
Rakesh K. Singh, Ying Dai, Jeff L. Staudinger
and Nancy A. Muma
The
International Journal of Neuropsychopharmacology
(2009), 12:651-665
3! - No regional difference
in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in
humans: a positron emission tomography study
Hiroshi Ito, Ryosuke Arakawa, Hidehiko Takahashi, Harumasa Takano, Masaki Okumura, Tatsui Otsuka, Yoko Ikoma,
Miho Shidahara and Tetsuya Suhara
The
International Journal of Neuropsychopharmacology
(2009), 12:667-675
3 - The relationship between subjective well-being and dopamine
D2 receptors in patients
treated with a dopamine partial agonist and full antagonist antipsychotics
Romina Mizrahi,
David Mamo, Pablo Rusjan, Ariel Graff,
Sylvain Houle and Shitij Kapur
The
International Journal of Neuropsychopharmacology
(2009), 12:715-721
GRATIS 3 - Cardiac Risks Hold Up Approval
of Two Antipsychotics
Jun
Yan
Psychiatr News
May 15, 2009, Volume 44, Number
10, page 2
3 - Psychosocial Functioning in Patients
with Schizophrenia Treated with Aripiprazole
- an Office-based Real-world Setting. Results from the
German Post-marketing Surveillance
Study
F. Bergmann,
A. Zacher, A. Nass,
R. Urban, C. Werner, T. Spevakné-Göröcs, M. Kungel, M. Ebrecht, S. Modell
Pharmacopsychiatry 2009; 42: 101-108
3 - Switching to Aripiprazole
in Outpatients with Schizophrenia Experiencing Insufficient Efficacy and/or Safety/Tolerability Issues with Risperidone: A Randomized, Multicentre, Open-label Study
V. Ryckmans, J. P. Kahn, S. Modell,
C. Werner, R. D. McQuade, W. Kerselaers, J. Lissens,
R. Sanchez
Pharmacopsychiatry 2009; 42: 114-121
3! - Schizophrenia, Substance Abuse, and Violent Crime
Seena Fazel, Niklas Långström,
Anders Hjern, Martin Grann, Paul Lichtenstein
GRATIS 3 - Update on the management
of symptoms in schizophrenia: focus on amisulpride
Ann M Mortimer
Neuropsychiatric Disease and
Treatment. May 2009
3 -
Use and Safety of Antipsychotic Drugs During Pregnancy
Einarson, Adrienne; Boskovic, Rada
Journal of Psychiatric Practice: May 2009 - Volume 15 - Issue 3 - pp 183-192
3 - Akathisia: An Updated
Review Focusing on Second-Generation
Antipsychotics
John M. Kane, Wolfgang W. Fleischhacker, Lars Hansen, Roy Perlis,
Andrei Pikalov III, and Sheila Assunção-Talbott
J Clin Psychiatry 2009;70(5):627-643
3 - Comparing the Effectiveness
of Aripiprazole and Quetiapine in Schizophrenia and Related Psychoses: A Naturalistic, Retrospective Chart Review Study
Polash Shajahan, Sonia Keith, Chetan Majjiga, Jennifer Murphy,
Alison MacRae, Muhammad Bashir, and
Mark Taylor
J Clin Psychiatry 2009;70(5):692-698
3! - Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison
Benedicto Crespo-Facorro,
José M. Rodríguez-Sánchez, Rocío Pérez-Iglesias, Ignacio Mata, Rosa Ayesa, MariLuz Ramirez-Bonilla, Obdulia Martínez-Garcia,
and José L. Vázquez-Barquero
J Clin Psychiatry 2009;70(5):717-729
3 - Effects of the
CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia
Tatsuhiko Yagihashi, Masafumi Mizuno, Bun Chino, Yuji Sato, Kei Sakuma, Toru Takebayashi,
Takahashi Takao, Kenjiro Kosaki
Human
Psychopharmacology: Clinical
and Experimental. Volume 24 Issue
4, Pages 301 - 308
GRATIS 3 (previo
registro) - Cotard’s Syndrome: A Review
Current Psychiatry Reports 2009, 11: (3)
197-202
| Regresar a RESÚMENES MAYO 2009 |